Janux Therapeutics, Inc.
JANX
11 insider filings · Latest: Jul 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Sep 27 8:51 PM | Avalon BioVentures I, LP | Proposed Sale | 9,187 | $46.43 | $426.5K | — | View → |
| Sep 27, 2024 | Sep 27 8:51 PM | Avalon Ventures XI, L.P. | Proposed Sale | 47,405 | $46.43 | $2.2M | — | View → |
| Sep 27, 2024 | Sep 27 8:24 PM | THOMAS DIRAIMONDO | Proposed Sale | 5,000 | $46.62 | $233.1K | — | View → |
| Sep 27, 2024 | Sep 27 8:18 PM | Reardon Tighe | Proposed Sale | 4,832 | $46.18 | $223.2K | — | View → |
| Sep 27, 2024 | Sep 27 8:05 PM | Campbell David Alan | Proposed Sale | 90,000 | $48.33 | $4.3M | — | View → |
| Sep 27, 2024 | Sep 27 8:01 PM | ANDY MEYER | Proposed Sale | 50,000 | $45.96 | $2.3M | — | View → |
| Sep 26, 2024 | Sep 26 9:57 PM | Avalon Ventures XI, L.P. | Proposed Sale | 90,300 | $47.19 | $4.3M | — | View → |
| Sep 26, 2024 | Sep 26 9:35 PM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 92,200 | $47.19 | $4.4M | — | View → |
| Sep 26, 2024 | Sep 26 9:13 PM | Avalon BioVentures I, LP | Proposed Sale | 17,500 | $47.19 | $825.7K | — | View → |
| Sep 13, 2024 | Sep 13 9:01 PM | Lichter Jay | Proposed Sale | 3,815 | $46.68 | $178.1K | — | View → |
| Sep 12, 2024 | Sep 13 1:18 AM | Avalon BioVentures I, LP | Proposed Sale | 30,613 | $47.00 | $1.4M | — | View → |
| Sep 12, 2024 | Sep 13 1:07 AM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 161,356 | $47.00 | $7.6M | — | View → |
| Sep 12, 2024 | Sep 13 12:54 AM | Avalon Ventures XI, L.P. | Proposed Sale | 158,031 | $47.00 | $7.4M | — | View → |
| Sep 12, 2024 | Sep 12 10:23 PM | Reardon Tighe | Proposed Sale | 15,223 | $47.42 | $721.9K | — | View → |
| Sep 12, 2024 | Sep 12 8:51 PM | Reardon Tighe | Proposed Sale | 8,819 | $47.77 | $421.3K | — | View → |
| Sep 10, 2024 | Sep 11 3:20 PM | Reardon Tighe | Proposed Sale | 2,055 | $46.50 | $95.6K | — | View → |
| Sep 10, 2024 | Sep 10 10:32 PM | Avalon BioVentures I, LP | Proposed Sale | 8,842 | $45.52 | $402.5K | — | View → |
| Sep 10, 2024 | Sep 10 10:26 PM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 46,604 | $45.52 | $2.1M | — | View → |
| Sep 10, 2024 | Sep 10 10:22 PM | Avalon Ventures XI, L.P. | Proposed Sale | 45,645 | $45.52 | $2.1M | — | View → |
| Sep 10, 2024 | Sep 10 9:51 PM | Reardon Tighe | Proposed Sale | 3,304 | $45.47 | $150.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Jul 11 12:00 AM | Campbell David AlanDirector, President and CEO | Option Exercise | 7,000 | $4.21 | 697,550(D) | View → |
| Jun 11, 2026 | Jun 13 12:30 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 15,500 | $13.66 | 15,500(I) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Jake SimsonDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Winston KungDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Natasha HerndayDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Eric DobmeierDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Vickie L CappsDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Ronald W BarrettDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Feb 2, 2026 | Feb 5 1:01 AM | William GoChief Medical Officer | Grant/Award | 154,000 | $13.99 | 154,000(D) | View → |